Wilmington Savings Fund Society FSB Trims Position in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Wilmington Savings Fund Society FSB trimmed its position in iRhythm Technologies, Inc. (NASDAQ:IRTC) by 37.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,000 shares of the company’s stock after selling 600 shares during the period. Wilmington Savings Fund Society FSB’s holdings in iRhythm Technologies were worth $90,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. State Street Corp grew its stake in iRhythm Technologies by 1.3% in the third quarter. State Street Corp now owns 908,843 shares of the company’s stock worth $67,473,000 after purchasing an additional 11,992 shares during the period. Braidwell LP grew its stake in iRhythm Technologies by 48.7% in the third quarter. Braidwell LP now owns 782,557 shares of the company’s stock worth $58,097,000 after purchasing an additional 256,200 shares during the period. Eventide Asset Management LLC grew its stake in iRhythm Technologies by 170.8% in the third quarter. Eventide Asset Management LLC now owns 736,721 shares of the company’s stock worth $54,694,000 after purchasing an additional 464,629 shares during the period. Geode Capital Management LLC grew its stake in iRhythm Technologies by 0.7% in the third quarter. Geode Capital Management LLC now owns 733,308 shares of the company’s stock worth $54,451,000 after purchasing an additional 5,423 shares during the period. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its stake in iRhythm Technologies by 38.1% in the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 707,175 shares of the company’s stock worth $52,501,000 after purchasing an additional 195,246 shares during the period.

Insider Activity

In related news, insider Patrick Michael Murphy sold 2,492 shares of the company’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $85.89, for a total transaction of $214,037.88. Following the completion of the sale, the insider now owns 35,327 shares in the company, valued at approximately $3,034,236.03. This represents a 6.59 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.68% of the company’s stock.

Analyst Upgrades and Downgrades

IRTC has been the topic of several recent research reports. Oppenheimer upped their price target on iRhythm Technologies from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 8th. Needham & Company LLC boosted their target price on iRhythm Technologies from $96.00 to $112.00 and gave the stock a “buy” rating in a report on Monday, January 13th. Wells Fargo & Company reissued an “equal weight” rating and issued a $86.00 target price on shares of iRhythm Technologies in a report on Tuesday, December 3rd. Truist Financial boosted their target price on iRhythm Technologies from $85.00 to $111.00 and gave the stock a “buy” rating in a report on Wednesday, December 18th. Finally, Canaccord Genuity Group boosted their target price on iRhythm Technologies from $125.00 to $152.00 and gave the stock a “buy” rating in a report on Monday, December 9th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, iRhythm Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $108.45.

iRhythm Technologies Trading Up 0.9 %

Shares of NASDAQ:IRTC opened at $112.19 on Friday. The company has a market cap of $3.51 billion, a P/E ratio of -23.08 and a beta of 1.29. The company has a debt-to-equity ratio of 9.00, a current ratio of 6.27 and a quick ratio of 6.12. iRhythm Technologies, Inc. has a 1 year low of $55.92 and a 1 year high of $124.11. The stock’s fifty day moving average price is $97.91 and its 200-day moving average price is $82.09.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.